Thomas Condamine

Company: Carisma Therapeutics

Job title: Vice President, Discovery & Translational Sciences

Seminars:

Pioneering Engineered Macrophages in Oncology & Beyond 1:30 pm

Exploring CAR-M platform for solid tumor immunotherapy Reviewing the clinical program overview of Anti-HER2 CAR-M ex vivo cell therapy Utilizing direct in vivo CAR reprogramming for oncology and other disease areasRead more

day: Post-Conference Solid Tumor Focus Day